Related Experiment Video
Updated: Jul 17, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Bacterial infections of the lung in normal and immunodeficient patients
1Room 377, Child and Family Research Institute, 950 West 28th Avenue, Vancouver BC, Canada, V5Z 4H4.
Abstract:
The lung is exposed to enormous quantities of air and to potentially infectious agents, but serious infections rarely occur, a testament to the extraordinary natural defences of the respiratory tract. The most common causes of bacterial lung infections in normal hosts include Streptococcus pneumoniae, Haemophilus species, Staphylococcus aureus and Mycobacterium tuberculosis. In compromised hosts, the bacterial causes of pneumonia are much broader, including species not usually considered of high virulence in humans. Indeed infection with one of these unusual bacterial species demands a search for an immunocompromising condition. Normal defences of the respiratory tract include non-specific physical factors (the 'mucociliary escalator'), and innate factors, including defensins, lysozyme and phagocytic cells (polymorphonuclear leukocytes, pulmonary alveolar macrophages and dendritic cells). Antibacterial defences are enhanced by opsonins, including those intrinsically present (surfactant and complement components) and induced immunoglobulins. Immunocompromising conditions, in which bacterial lung infections frequently occur, include (but are not limited to) hypogammaglobulinaemia, chronic granulomatous disease and primary ciliary dyskinesia. Each of these conditions illustrates the essential role of the disabled element of the innate and adaptive immune system in maintaining sterility of the lower respiratory tract.
Insights
The lungs possess remarkable natural defenses against airborne pathogens. However, in individuals with weakened immune systems, a wider range of bacteria can cause severe lung infections, indicating an underlying immunocompromising condition.
Area of Science:
- Immunology
- Pulmonology
- Microbiology
Background:
- The respiratory tract possesses robust natural defenses against inhaled pathogens.
- Common bacterial lung infections in healthy individuals are typically caused by specific pathogens like Streptococcus pneumoniae.
- In immunocompromised hosts, a broader spectrum of bacteria, including less virulent species, can cause pneumonia.
Purpose of the Study:
- To highlight the critical role of the immune system in preventing bacterial lung infections.
- To underscore the importance of investigating immunocompromising conditions when unusual bacterial lung pathogens are identified.
- To detail the multifaceted defense mechanisms of the respiratory tract.
Main Methods:
- Review of established knowledge on respiratory tract defenses.
- Analysis of common and opportunistic bacterial pathogens causing lung infections.
- Examination of various immunocompromising conditions affecting lung immunity.
Main Results:
- Respiratory defenses include physical barriers (mucociliary escalator) and innate factors (defensins, lysozyme, phagocytes).
- Adaptive immunity, enhanced by opsonins (surfactant, complement, immunoglobulins), further protects against bacterial invasion.
- Immunocompromising conditions such as hypogammaglobulinaemia, chronic granulomatous disease, and primary ciliary dyskinesia predispose individuals to severe bacterial pneumonia.
Conclusions:
- The integrity of both innate and adaptive immune systems is essential for maintaining a sterile lower respiratory tract.
- Identifying unusual bacterial lung pathogens necessitates a thorough search for underlying immunocompromising conditions.
- Understanding these defense mechanisms and vulnerabilities is crucial for managing and preventing lung infections.
Related Concept Videos
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Microbiota of the Respiratory Tract
Pneumonia II: Pathophysiology
Atypical Pneumonia
Pneumonia III: Complications and Assessment

